Epigenetic resensitization to platinum in recurrent, platinum-resistant ovarian cancer (OC) using guadecitabine (SGI-110), a novel hypomethylating agent (HMA): Results of a randomized phase II study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Matulonis, Ursula A
  • Oza, Amit M
  • Secord, Angeles Alvarez
  • Roman, Lynda D
  • Blagden, Sarah Patricia
  • Banerjee, Susana N
  • Elkas, JC
  • Nemunaitis, John J
  • Ghamande, Sharad A
  • Fleming, Gini F
  • Markham, Merry Jennifer
  • Hirte, Holger
  • Provencher, Diane M
  • Basu, Bristi
  • Kristeleit, Rebecca Sophie
  • Naim, Sue
  • Hao, Yong
  • Keer, Harold N
  • Azab, Mohammad
  • Matei, Daniela

publication date

  • May 20, 2016